GlaxoSmithKline Plc's (GSK) sales in China jumped 20 percent to about 1 billion pounds ($1.5 billion) last year, almost quadruple the pace of growth across its emerging markets. Police say bribes and sexual favors spurred the gain.
http://is.gd/gBxwfG
Sent via BlackBerry by Union Paradise
Stocks Rise After Tumult, but Investors Remain Wary of Trade Tensions
-
Markets steadied on Wednesday, despite uncertainty spurred by tit-for-tat
tariffs and the direction of the Trump administration’s economic policy.
No comments:
Post a Comment